1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B93C1828B59E997D85256C63005B42C2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/trademark-branding-decisions-setting-a-strategy?opendocument
18
19opendocument
2054.198.246.164
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Branding and Identity

Trademark Branding Decisions: Setting a Strategy

DB Image

ID: 4303


Features:

Graphics


Words: 4,752


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Trademark strategy no longer refers just to setting the course for developing, launching and marketing a single product. Rather it entails value optimization for a new molecular entity. Increasingly, benchmark companies reflected, this means bringing multiple indications and formulations into the marketplace. This 15-page document, geared to pharmaceutical marketing and brand team executives, examines how best practice companies make trademark and branding decisions in the broader context of strategy, lifecycle management and compound value optimization. It also details how companies understand the different needs of patients, providers, payers and pharmacists through extensive market research and use the insights to drive trademark and branding decisions.

It includes advice on:

Identifying the conflicts and synergies among indications to decide between single, dual or hybrid trademark approaches

Analyzing all target customer segments to establish optimal marketing and sales communications to patients, providers, payers and pharmacists

Evaluating payer requirements and reimbursement issues to reap the highest economic return

Industries Profiled:
Market Research; Manufacturing; Medical Device; Pharmaceutical; Financial Services; Service; Retail; Research; Computer Software; Diagnostic; Health Care; Transportation; Biotech; Clinical Research; Consulting; Distribution; Insurance; Hospitality; Telecommunications; Technology; Professional Services; High Tech; Automobile; Utilities; Energy; Consumer Products; Chemical; Medical; Electronics; Laboratories; Biopharmaceutical; Banking; Computers; Entertainment; Internet; Computer Hardware; Aerospace; Academic; Media; Education; Newspapers; Government; Shipping; Science; Office Supplies; Marketing; Office Equipment; Cable; Advertising; Defense; Military; Diversified; Sports; Technology; Public Relations; Multiple; Communications; Logistics; Publishing; Real Estate; Construction; Architecture; Engineering; Aviation; Legal; Test Industry; Non-Profit; Business; Orthopaedics


Companies Profiled:

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.